Youcare Pharmaceutical Group to Terminate Coding System Project

MT Newswires15:31

Youcare Pharmaceutical Group (688658.SH): plans to use the remaining raised surplus funds of 38.4278 million yuan to permanently supplement working capital.

On December 18, Gulonhui reported that Youcare Pharmaceutical Group (688658.SH) held the 17th meeting of the second Board of Directors and the 15th meeting of the second Supervisory Board on December 18, 2024. They reviewed and approved the proposal to permanently use the remaining over-raised funds for replenishing working capital, agreeing to use the remaining over-raised funds of 38.4278 million yuan (including interest and cash management income, with the specific amount based on the actual amount at the time of transfer) to permanently supplement working capital, which accounts for 7.50% of the total over-raised amount.

Gelonghui FinanceDec 18 19:54

Youcare Pharmaceutical Group (688658.SH): Termination of some fundraising investment projects.

On December 18th, Gelonghui reported that Youcare Pharmaceutical Group (688658.SH) announced that the fundraising investment project "Intelligent Coding System Construction Project" was developed by the company in consideration of factors such as the current market environment, Industry development trends, and the company's actual situation. Although the company conducted sufficient research and demonstrations at the project's initiation, in recent years, there have been significant changes in the pharmaceutical Industry and the generic drug market. Additionally, influenced by several uncontrollable factors such as the company's external severe situation and local policy changes, the company plans to decide, in light of actual Business needs, to improve the efficiency of the raised funds and ensure their effective use.

Gelonghui FinanceDec 18 18:56

Express News | Orient has given Youcare Pharmaceutical Group Co., Ltd. an initial rating of 'buy'.

BreakingsDec 10 21:35

Youcare Pharmaceutical's Cefprozil Tablets Pass Regulator's Consistency Evaluation

MT NewswiresDec 6 15:00

Youcare Pharmaceutical's Unit Gets Nod to Trial Herpes Drug in US

MT NewswiresDec 6 14:43